Autophagy, lipophagy and lysosomal lipid storage disorders

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1861, Issue 4, 2016, Pages 269-284

  Ward, Carl ^a   Martinez Lopez, Nuria ^b,c   Otten, Elsje G ^c   Carroll, Bernadette ^c   Maetzel, Dorothea ^d   Singh, Rajat ^b,c   Sarkar, Sovan ^a   Korolchuk, Viktor I ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Autophagy; Lipid metabolism; Lipid storage disorders

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; RECEPTOR PROTEIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MTOR PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE;

AUTOPHAGY; FABRY DISEASE; FATTY LIVER; GAUCHER DISEASE; GLYCOGEN STORAGE DISEASE; GM1 GANGLIOSIDOSIS; HUMAN; LIPID METABOLISM; LIPIDOSIS; LIPOPHAGOCYTOSIS; LYSOSOME STORAGE DISEASE; MUCOLIPIDOSIS TYPE 4; MUCOPOLYSACCHARIDOSIS; NEURONAL CEROID LIPOFUSCINOSIS; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; GENETICS; LYSOSOME; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; FATTY LIVER; HUMANS; LIPID METABOLISM; LIPID METABOLISM, INBORN ERRORS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; MULTIPROTEIN COMPLEXES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84956711163     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2016.01.006     Document Type: Review

References (248)

1. C. De Duve, and R. Wattiaux Functions of lysosomes Annu. Rev. Physiol. 28 1966 435 492
2. C.A. Lamb, T. Yoshimori, and S.A. Tooze The autophagosome: origins unknown, biogenesis complex Nat. Rev. Mol. Cell Biol. 14 2013 759 774
3. B. Ravikumar, K. Moreau, L. Jahreiss, C. Puri, and D.C. Rubinsztein Plasma membrane contributes to the formation of pre-autophagosomal structures Nat. Cell Biol. 12 2010 747 757
4. P. Yla-Anttila, H. Vihinen, E. Jokitalo, and E.L. Eskelinen 3D tomography reveals connections between the phagophore and endoplasmic reticulum Autophagy 5 2009 1180 1185
5. D.W. Hailey, A.S. Rambold, P. Satpute-Krishnan, K. Mitra, R. Sougrat, P.K. Kim, and J. Lippincott-Schwartz Mitochondria supply membranes for autophagosome biogenesis during starvation Cell 141 2010 656 667
6. M. Hamasaki, N. Furuta, A. Matsuda, A. Nezu, A. Yamamoto, N. Fujita, H. Oomori, T. Noda, T. Haraguchi, Y. Hiraoka, A. Amano, and T. Yoshimori Autophagosomes form at ER-mitochondria contact sites Nature 495 2013 389 393
7. L. Ge, D. Melville, M. Zhang, and R. Schekman The ER-Golgi intermediate compartment is a key membrane source for the LC3 lipidation step of autophagosome biogenesis Elife 2 2013 e00947
8. M. Hayashi-Nishino, N. Fujita, T. Noda, A. Yamaguchi, T. Yoshimori, and A. Yamamoto A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation Nat. Cell Biol. 11 2009 1433 1437
9. D. Mijaljica, M. Prescott, and R.J. Devenish Microautophagy in mammalian cells: revisiting a 40-year-old conundrum Autophagy 7 2011 673 682
10. H.L. Chiang, S.R. Terlecky, C.P. Plant, and J.F. Dice A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins Science (New York, N.Y.) 246 1989 382 385
11. S.J. Orenstein, and A.M. Cuervo Chaperone-mediated autophagy: molecular mechanisms and physiological relevance Semin. Cell Dev. Biol. 21 2010 719 726
12. A.M. Cuervo, and J.F. Dice A receptor for the selective uptake and degradation of proteins by lysosomes Science (New York, N.Y.) 273 1996 501 503
13. Y. Ohsumi Historical landmarks of autophagy research Cell Res. 24 2014 9 23
14. Y. Feng, D. He, Z. Yao, and D.J. Klionsky The machinery of macroautophagy Cell Res. 24 2014 24 41
15. I. Tanida, Y.S. Sou, J. Ezaki, N. Minematsu-Ikeguchi, T. Ueno, and E. Kominami HsAtg4B/HsApg4B/autophagin-1 cleaves the carboxyl termini of three human Atg8 homologues and delipidates microtubule-associated protein light chain 3- and GABAA receptor-associated protein-phospholipid conjugates J. Biol. Chem. 279 2004 36268 36276
16. T. Shintani, N. Mizushima, Y. Ogawa, A. Matsuura, T. Noda, and Y. Ohsumi Apg10p, a novel protein-conjugating enzyme essential for autophagy in yeast EMBO J. 18 1999 5234 5241
17. A. Kuma, N. Mizushima, N. Ishihara, and Y. Ohsumi Formation of the approximately 350-kDa Apg12-Apg5.Apg16 multimeric complex, mediated by Apg16 oligomerization, is essential for autophagy in yeast J. Biol. Chem. 277 2002 18619 18625
18. N. Mizushima, A. Kuma, Y. Kobayashi, A. Yamamoto, M. Matsubae, T. Takao, T. Natsume, Y. Ohsumi, and T. Yoshimori Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate J. Cell Sci. 116 2003 1679 1688
19. X.H. Liang, S. Jackson, M. Seaman, K. Brown, B. Kempkes, H. Hibshoosh, and B. Levine Induction of autophagy and inhibition of tumorigenesis by beclin 1 Nature 402 1999 672 676
20. Y. Kabeya, N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, T. Noda, E. Kominami, Y. Ohsumi, and T. Yoshimori LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing EMBO J. 19 2000 5720 5728
21. H. Nakatogawa, J. Ishii, E. Asai, and Y. Ohsumi Atg4 recycles inappropriately lipidated Atg8 to promote autophagosome biogenesis Autophagy 8 2012 177 186
22. T. Hanada, N.N. Noda, Y. Satomi, Y. Ichimura, Y. Fujioka, T. Takao, F. Inagaki, and Y. Ohsumi The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy J. Biol. Chem. 282 2007 37298 37302
23. N. Mizushima, A. Yamamoto, M. Hatano, Y. Kobayashi, Y. Kabeya, K. Suzuki, T. Tokuhisa, Y. Ohsumi, and T. Yoshimori Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells J. Cell Biol. 152 2001 657 668
24. M. Komatsu, S. Waguri, T. Ueno, J. Iwata, S. Murata, I. Tanida, J. Ezaki, N. Mizushima, Y. Ohsumi, Y. Uchiyama, E. Kominami, K. Tanaka, and T. Chiba Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice J. Cell Biol. 169 2005 425 434
25. P.B. Gordon, and P.O. Seglen Prelysosomal convergence of autophagic and endocytic pathways Biochem. Biophys. Res. Commun. 151 1988 40 47
26. D.J. Klionsky Autophagy: from phenomenology to molecular understanding in less than a decade Nat. Rev. Mol. Cell Biol. 8 2007 931 937
27. S. Sarkar, G. Horn, K. Moulton, A. Oza, S. Byler, S. Kokolus, and M. Longacre Cancer development, progression, and therapy: an epigenetic overview Int. J. Mol. Sci. 14 2013 21087 21113
28. S. Jager, C. Bucci, I. Tanida, T. Ueno, E. Kominami, P. Saftig, and E.L. Eskelinen Role for Rab7 in maturation of late autophagic vacuoles J. Cell Sci. 117 2004 4837 4848
29. A. Kihara, Y. Kabeya, Y. Ohsumi, and T. Yoshimori Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network EMBO Rep. 2 2001 330 335
30. N. Furuya, J. Yu, M. Byfield, S. Pattingre, and B. Levine The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function Autophagy 1 2005 46 52
31. R. Kang, H.J. Zeh, M.T. Lotze, and D. Tang The beclin 1 network regulates autophagy and apoptosis Cell Death Differ. 18 2011 571 580
32. Y. Zhong, Q.J. Wang, X. Li, Y. Yan, J.M. Backer, B.T. Chait, N. Heintz, and Z. Yue Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex Nat. Cell Biol. 11 2009 468 476
33. S. Di Bartolomeo, M. Corazzari, F. Nazio, S. Oliverio, G. Lisi, M. Antonioli, V. Pagliarini, S. Matteoni, C. Fuoco, L. Giunta, M. D'Amelio, R. Nardacci, A. Romagnoli, M. Piacentini, F. Cecconi, and G.M. Fimia The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy J. Cell Biol. 191 2010 155 168
34. C. Liang, J.S. Lee, K.S. Inn, M.U. Gack, Q. Li, E.A. Roberts, I. Vergne, V. Deretic, P. Feng, C. Akazawa, and J.U. Jung Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking Nat. Cell Biol. 10 2008 776 787
35. Y.A. Chen, and R.H. Scheller SNARE-mediated membrane fusion Nat. Rev. Mol. Cell Biol. 2 2001 98 106
36. E. Itakura, C. Kishi-Itakura, and N. Mizushima The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes Cell 151 2012 1256 1269
37. J. Diao, R. Liu, Y. Rong, M. Zhao, J. Zhang, Y. Lai, Q. Zhou, L.M. Wilz, J. Li, S. Vivona, R.A. Pfuetzner, A.T. Brunger, and Q. Zhong ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes Nature 520 2015 563 566
38. Y. Nishida, S. Arakawa, K. Fujitani, H. Yamaguchi, T. Mizuta, T. Kanaseki, M. Komatsu, K. Otsu, Y. Tsujimoto, and S. Shimizu Discovery of Atg5/Atg7-independent alternative macroautophagy Nature 461 2009 654 658
39. S. Honda, S. Arakawa, Y. Nishida, H. Yamaguchi, E. Ishii, and S. Shimizu Ulk1-mediated Atg5-independent macroautophagy mediates elimination of mitochondria from embryonic reticulocytes Nat. Commun. 5 2014 4004
40. T. Ma, J. Li, Y. Xu, C. Yu, T. Xu, H. Wang, K. Liu, N. Cao, B.M. Nie, S.Y. Zhu, S. Xu, K. Li, W.G. Wei, Y. Wu, K.L. Guan, and S. Ding Atg5-independent autophagy regulates mitochondrial clearance and is essential for iPSC reprogramming Nat. Cell Biol. 17 2015 1379 1387
41. T. Noda, and Y. Ohsumi Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast J. Biol. Chem. 273 1998 3963 3966
42. R.C. Scott, O. Schuldiner, and T.P. Neufeld Role and regulation of starvation-induced autophagy in the Drosophila fat body Dev. Cell 7 2004 167 178
43. M. Laplante, and D.M. Sabatini mTOR signaling in growth control and disease Cell 149 2012 274 293
44. J.L. Jewell, and K.L. Guan Nutrient signaling to mTOR and cell growth Trends Biochem. Sci. 38 2013 233 242
45. C.G. Proud Control of the translational machinery by amino acids Am. J. Clin. Nutr. 99 2014 231s 236s
46. B. Carroll, V.I. Korolchuk, and S. Sarkar Amino acids and autophagy: cross-talk and co-operation to control cellular homeostasis Amino Acids 47 2015 2065 2088
47. N. Hosokawa, T. Hara, T. Kaizuka, C. Kishi, A. Takamura, Y. Miura, S. Iemura, T. Natsume, K. Takehana, N. Yamada, J.L. Guan, N. Oshiro, and N. Mizushima Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy Mol. Biol. Cell 20 2009 1981 1991
48. C.H. Jung, C.B. Jun, S.H. Ro, Y.M. Kim, N.M. Otto, J. Cao, M. Kundu, and D.H. Kim ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery Mol. Biol. Cell 20 2009 1992 2003
49. I.G. Ganley, H. Lam du, J. Wang, X. Ding, S. Chen, and X. Jiang ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy J. Biol. Chem. 284 2009 12297 12305
50. I. Koren, E. Reem, and A. Kimchi DAP1, a novel substrate of mTOR, negatively regulates autophagy Curr. Biol. CB 20 2010 1093 1098
51. J.A. Martina, Y. Chen, M. Gucek, and R. Puertollano MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB Autophagy 8 2012 903 914
52. G. Hu, T. McQuiston, A. Bernard, Y.D. Park, J. Qiu, A. Vural, N. Zhang, S.R. Waterman, N.H. Blewett, T.G. Myers, R.J. Maraia, J.H. Kehrl, G. Uzel, D.J. Klionsky, and P.R. Williamson A conserved mechanism of TOR-dependent RCK-mediated mRNA degradation regulates autophagy Nat. Cell Biol. 17 2015 930 942
53. X. Bai, D. Ma, A. Liu, X. Shen, Q.J. Wang, Y. Liu, and Y. Jiang Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38 Science (New York, N.Y.) 318 2007 977 980
54. Y. Sancak, T.R. Peterson, Y.D. Shaul, R.A. Lindquist, C.C. Thoreen, L. Bar-Peled, and D.M. Sabatini The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1 Science (New York, N.Y.) 320 2008 1496 1501
55. Y. Sancak, L. Bar-Peled, R. Zoncu, A.L. Markhard, S. Nada, and D.M. Sabatini Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids Cell 141 2010 290 303
56. E. Kim, P. Goraksha-Hicks, L. Li, T.P. Neufeld, and K.L. Guan Regulation of TORC1 by Rag GTPases in nutrient response Nat. Cell Biol. 10 2008 935 945
57. M. Gao, and C.A. Kaiser A conserved GTPase-containing complex is required for intracellular sorting of the general amino-acid permease in yeast Nat. Cell Biol. 8 2006 657 667
58. A. Petiot, E. Ogier-Denis, E.F. Blommaart, A.J. Meijer, and P. Codogno Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells J. Biol. Chem. 275 2000 992 998
59. L.C. Cantley The phosphoinositide 3-kinase pathway Science (New York, N.Y.) 296 2002 1655 1657
60. K. Inoki, Y. Li, T. Zhu, J. Wu, and K.L. Guan TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Nat. Cell Biol. 4 2002 648 657
61. Y. Zhang, X. Gao, L.J. Saucedo, B. Ru, B.A. Edgar, and D. Pan Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins Nat. Cell Biol. 5 2003 578 581
62. C. Demetriades, N. Doumpas, and A.A. Teleman Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2 Cell 156 2014 786 799
63. K. Inoki, H. Ouyang, T. Zhu, C. Lindvall, Y. Wang, X. Zhang, Q. Yang, C. Bennett, Y. Harada, K. Stankunas, C.Y. Wang, X. He, O.A. MacDougald, M. You, B.O. Williams, and K.L. Guan TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth Cell 126 2006 955 968
64. J. Kim, M. Kundu, B. Viollet, and K.L. Guan AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 Nat. Cell Biol. 13 2011 132 141
65. D. Benjamin, M. Colombi, C. Moroni, and M.N. Hall Rapamycin passes the torch: a new generation of mTOR inhibitors Nat. Rev. Drug Discov. 10 2011 868 880
66. J. Li, S.G. Kim, and J. Blenis Rapamycin: one drug, many effects Cell Metab. 19 2014 373 379
67. S. Sarkar, R.A. Floto, Z. Berger, S. Imarisio, A. Cordenier, M. Pasco, L.J. Cook, and D.C. Rubinsztein Lithium induces autophagy by inhibiting inositol monophosphatase J. Cell Biol. 170 2005 1101 1111
68. A. Williams, S. Sarkar, P. Cuddon, E.K. Ttofi, S. Saiki, F.H. Siddiqi, L. Jahreiss, A. Fleming, D. Pask, P. Goldsmith, C.J. O'Kane, R.A. Floto, and D.C. Rubinsztein Novel targets for Huntington's disease in an mTOR-independent autophagy pathway Nat. Chem. Biol. 4 2008 295 305
69. I.G. Ganley, P.M. Wong, N. Gammoh, and X. Jiang Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest Mol. Cell 42 2011 731 743
70. S. Sarkar Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers Biochem. Soc. Trans. 41 2013 1103 1130
71. M.M. Lipinski, G. Hoffman, A. Ng, W. Zhou, B.F. Py, E. Hsu, X. Liu, J. Eisenberg, J. Liu, J. Blenis, R.J. Xavier, and J. Yuan A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions Dev. Cell 18 2010 1041 1052
72. S. Sarkar, J.E. Davies, Z. Huang, A. Tunnacliffe, and D.C. Rubinsztein Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein J. Biol. Chem. 282 2007 5641 5652
73. S. Sarkar, E.O. Perlstein, S. Imarisio, S. Pineau, A. Cordenier, R.L. Maglathlin, J.A. Webster, T.A. Lewis, C.J. O'Kane, S.L. Schreiber, and D.C. Rubinsztein Small molecules enhance autophagy and reduce toxicity in Huntington's disease models Nat. Chem. Biol. 3 2007 331 338
74. D.C. Rubinsztein, P. Codogno, and B. Levine Autophagy modulation as a potential therapeutic target for diverse diseases Nat. Rev. Drug Discov. 11 2012 709 730
75. B. Levine, M. Packer, and P. Codogno Development of autophagy inducers in clinical medicine J. Clin. Invest. 125 2015 14 24
76. A. Khaminets, T. Heinrich, M. Mari, P. Grumati, A.K. Huebner, M. Akutsu, L. Liebmann, A. Stolz, S. Nietzsche, N. Koch, M. Mauthe, I. Katona, B. Qualmann, J. Weis, F. Reggiori, I. Kurth, C.A. Hubner, and I. Dikic Regulation of endoplasmic reticulum turnover by selective autophagy Nature 522 2015 354 358
77. I. Kim, S. Rodriguez-Enriquez, and J.J. Lemasters Selective degradation of mitochondria by mitophagy Arch. Biochem. Biophys. 462 2007 245 253
78. C. Kraft, A. Deplazes, M. Sohrmann, and M. Peter Mature ribosomes are selectively degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p ubiquitin protease Nat. Cell Biol. 10 2008 602 610
79. M.U. Hutchins, M. Veenhuis, and D.J. Klionsky Peroxisome degradation in Saccharomyces cerevisiae is dependent on machinery of macroautophagy and the Cvt pathway J. Cell Sci. 112 Pt 22 1999 4079 4087
80. R. Singh, S. Kaushik, Y. Wang, Y. Xiang, I. Novak, M. Komatsu, K. Tanaka, A.M. Cuervo, and M.J. Czaja Autophagy regulates lipid metabolism Nature 458 2009 1131 1135
81. R. Singh, and A.M. Cuervo Autophagy in the cellular energetic balance Cell Metab. 13 2011 495 504
82. L. Yang, P. Li, S. Fu, E.S. Calay, and G.S. Hotamisligil Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance Cell Metab. 11 2010 467 478
83. S. Kaushik, J.A. Rodriguez-Navarro, E. Arias, R. Kiffin, S. Sahu, G.J. Schwartz, A.M. Cuervo, and R. Singh Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance Cell Metab. 14 2011 173 183
84. M. Martinez-Vicente, Z. Talloczy, E. Wong, G. Tang, H. Koga, S. Kaushik, R. de Vries, E. Arias, S. Harris, D. Sulzer, and A.M. Cuervo Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease Nat. Neurosci. 13 2010 567 576
85. M. Ouimet, V. Franklin, E. Mak, X. Liao, I. Tabas, and Y.L. Marcel Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase Cell Metab. 13 2011 655 667
86. S.A. Khaldoun, M.A. Emond-Boisjoly, D. Chateau, V. Carriere, M. Lacasa, M. Rousset, S. Demignot, and E. Morel Autophagosomes contribute to intracellular lipid distribution in enterocytes Mol. Biol. Cell 25 2014 118 132
87. V.M. Hubbard, R. Valdor, B. Patel, R. Singh, A.M. Cuervo, and F. Macian Macroautophagy regulates energy metabolism during effector T cell activation J. Immunol. 185 2010 7349 7357
88. X. Xu, A. Grijalva, A. Skowronski, M. van Eijk, M.J. Serlie, and A.W. Ferrante Jr. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation Cell Metab. 18 2013 816 830
89. R.R. Kaini, L.O. Sillerud, S. Zhaorigetu, and C.A. Hu Autophagy regulates lipolysis and cell survival through lipid droplet degradation in androgen-sensitive prostate cancer cells Prostate 72 2012 1412 1422
90. T. van Zutphen, V. Todde, R. de Boer, M. Kreim, H.F. Hofbauer, H. Wolinski, M. Veenhuis, I.J. van der Klei, and S.D. Kohlwein Lipid droplet autophagy in the yeast Saccharomyces cerevisiae Mol. Biol. Cell 25 2014 290 301
91. L.R. Lapierre, S. Gelino, A. Melendez, and M. Hansen Autophagy and lipid metabolism coordinately modulate life span in germline-less C. elegans Curr. Biol. CB 21 2011 1507 1514
92. L.N. Nguyen, J. Bormann, G.T. Le, C. Starkel, S. Olsson, J.D. Nosanchuk, H. Giese, and W. Schafer Autophagy-related lipase FgATG15 of Fusarium graminearum is important for lipid turnover and plant infection Fungal Genet. Biol. FG B 48 2011 217 224
93. T. Kurusu, T. Koyano, S. Hanamata, T. Kubo, Y. Noguchi, C. Yagi, N. Nagata, T. Yamamoto, T. Ohnishi, Y. Okazaki, N. Kitahata, D. Ando, M. Ishikawa, S. Wada, A. Miyao, H. Hirochika, H. Shimada, A. Makino, K. Saito, H. Ishida, T. Kinoshita, N. Kurata, and K. Kuchitsu OsATG7 is required for autophagy-dependent lipid metabolism in rice postmeiotic anther development Autophagy 10 2014 878 888
94. A.R. Kimmel, D.L. Brasaemle, M. McAndrews-Hill, C. Sztalryd, and C. Londos Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins J. Lipid Res. 51 2010 468 471
95. R. Zimmermann, J.G. Strauss, G. Haemmerle, G. Schoiswohl, R. Birner-Gruenberger, M. Riederer, A. Lass, G. Neuberger, F. Eisenhaber, A. Hermetter, and R. Zechner Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase Science 306 2004 1383 1386
96. M. Vaughan, J.E. Berger, and D. Steinberg Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue J. Biol. Chem. 239 1964 401 409
97. R. Zimmermann, A. Lass, G. Haemmerle, and R. Zechner Fate of fat: the role of adipose triglyceride lipase in lipolysis Biochim. Biophys. Acta 1791 2009 494 500
98. S.C. Souza, K.V. Muliro, L. Liscum, P. Lien, M.T. Yamamoto, J.E. Schaffer, G.E. Dallal, X. Wang, F.B. Kraemer, M. Obin, and A.S. Greenberg Modulation of hormone-sensitive lipase and protein kinase A-mediated lipolysis by perilipin A in an adenoviral reconstituted system J. Biol. Chem. 277 2002 8267 8272
99. R. Zechner, R. Zimmermann, T.O. Eichmann, S.D. Kohlwein, G. Haemmerle, A. Lass, and F. Madeo FAT SIGNALS - lipases and lipolysis in lipid metabolism and signaling Cell Metab. 15 2012 279 291
100. X. Yang, X. Lu, M. Lombes, G.B. Rha, Y.I. Chi, T.M. Guerin, E.J. Smart, and J. Liu The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase Cell Metab. 11 2010 194 205
101. S. Kaushik, and A.M. Cuervo Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis Nat. Cell Biol. 17 2015 759 770
102. N. Dupont, S. Chauhan, J. Arko-Mensah, E.F. Castillo, A. Masedunskas, R. Weigert, H. Robenek, T. Proikas-Cezanne, and V. Deretic Neutral lipid stores and lipase PNPLA5 contribute to autophagosome biogenesis Curr. Biol. CB 24 2014 609 620
103. T. Shpilka, E. Welter, N. Borovsky, N. Amar, M. Mari, F. Reggiori, and Z. Elazar Lipid droplets and their component triglycerides and steryl esters regulate autophagosome biogenesis EMBO J. 34 2015 2117 2131
104. A.S. Rambold, S. Cohen, and J. Lippincott-Schwartz Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics Dev. Cell 32 2015 678 692
105. J. Spandl, D. Lohmann, L. Kuerschner, C. Moessinger, and C. Thiele Ancient ubiquitous protein 1 (AUP1) localizes to lipid droplets and binds the E2 ubiquitin conjugase G2 (Ube2g2) via its G2 binding region J. Biol. Chem. 286 2011 5599 5606
106. Z. Li, M.R. Johnson, Z. Ke, L. Chen, and M.A. Welte Drosophila lipid droplets buffer the H2Av supply to protect early embryonic development Curr. Biol. CB 24 2014 1485 1491
107. G. Xu, C. Sztalryd, and C. Londos Degradation of perilipin is mediated through ubiquitination-proteasome pathway Biochim. Biophys. Acta 1761 2006 83 90
108. J.L. Schneider, Y. Suh, and A.M. Cuervo Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation Cell Metab. 20 2014 417 432
109. S. Pankiv, T.H. Clausen, T. Lamark, A. Brech, J.A. Bruun, H. Outzen, A. Overvatn, G. Bjorkoy, and T. Johansen p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy J. Biol. Chem. 282 2007 24131 24145
110. T.L. Thurston, G. Ryzhakov, S. Bloor, N. von Muhlinen, and F. Randow The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria Nat. Immunol. 10 2009 1215 1221
111. Y.C. Wong, and E.L. Holzbaur Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation Proc. Natl. Acad. Sci. U. S. A. 111 2014 E4439 E4448
112. E. Deosaran, K.B. Larsen, R. Hua, G. Sargent, Y. Wang, S. Kim, T. Lamark, M. Jauregui, K. Law, J. Lippincott-Schwartz, A. Brech, T. Johansen, and P.K. Kim NBR1 acts as an autophagy receptor for peroxisomes J. Cell Sci. 126 2013 939 952
113. Y.N. Rui, Z. Xu, B. Patel, Z. Chen, D. Chen, A. Tito, G. David, Y. Sun, E.F. Stimming, H.J. Bellen, A.M. Cuervo, and S. Zhang Huntingtin functions as a scaffold for selective macroautophagy Nat. Cell Biol. 17 2015 262 275
114. M. Martinez-Vicente, and A.M. Cuervo Autophagy and neurodegeneration: when the cleaning crew goes on strike Lancet Neurol. 6 2007 352 361
115. C.T. Chu, J. Ji, R.K. Dagda, J.F. Jiang, Y.Y. Tyurina, A.A. Kapralov, V.A. Tyurin, N. Yanamala, I.H. Shrivastava, D. Mohammadyani, K.Z.Q. Wang, J. Zhu, J. Klein-Seetharaman, K. Balasubramanian, A.A. Amoscato, G. Borisenko, Z. Huang, A.M. Gusdon, A. Cheikhi, E.K. Steer, R. Wang, C. Baty, S. Watkins, I. Bahar, H. Bayir, and V.E. Kagan Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells Nat. Cell Biol. 15 2013 1197 1205
116. H. Koga, S. Kaushik, and A.M. Cuervo Altered lipid content inhibits autophagic vesicular fusion FASEB J. 24 2010 3052 3065
117. J.A. Rodriguez-Navarro, S. Kaushik, H. Koga, C. Dall'Armi, G. Shui, M.R. Wenk, G. Di Paolo, and A.M. Cuervo Inhibitory effect of dietary lipids on chaperone-mediated autophagy Proc. Natl. Acad. Sci. U. S. A. 109 2012 E705 E714
118. Y. Wang, R. Singh, Y. Xiang, and M.J. Czaja Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress Hepatology 52 2010 266 277
119. M. Amir, E. Zhao, L. Fontana, H. Rosenberg, K. Tanaka, G. Gao, and M.J. Czaja Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation Cell Death Differ. 20 2013 878 887
120. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
121. F.B. Kraemer, S. Patel, M.S. Saedi, and C. Sztalryd Detection of hormone-sensitive lipase in various tissues. I. Expression of an HSL/bacterial fusion protein and generation of anti-HSL antibodies J. Lipid Res. 34 1993 663 671
122. M. Goeritzer, N. Vujic, S. Schlager, P.G. Chandak, M. Korbelius, B. Gottschalk, C. Leopold, S. Obrowsky, S. Rainer, P. Doddapattar, E. Aflaki, M. Wegscheider, V. Sachdev, W.F. Graier, D. Kolb, B. Radovic, and D. Kratky Active autophagy but not lipophagy in macrophages with defective lipolysis Biochim. Biophys. Acta 1851 2015 1304 1316
123. A.P. Lieberman, R. Puertollano, N. Raben, S. Slaugenhaupt, S.U. Walkley, and A. Ballabio Autophagy in lysosomal storage disorders Autophagy 8 2012 719 730
124. F.M. Platt, B. Boland, and A.C. van der Spoel The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction J. Cell Biol. 199 2012 723 734
125. J.W. Callahan Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein Biochim. Biophys. Acta 1455 1999 85 103
126. N. Brunetti-Pierri, and F. Scaglia GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects Mol. Genet. Metab. 94 2008 391 396
127. Y. Suzuki, A. Oshima, and E. Namba C.R. Scriver, A. Beaudet, W.S. Sly, D. Valle, Metabolic Basis of Inherited Disease 2001 McGraw-Hill New York 3775 3809
128. A. Caciotti, S.C. Garman, Y. Rivera-Colon, E. Procopio, S. Catarzi, L. Ferri, C. Guido, P. Martelli, R. Parini, D. Antuzzi, R. Battini, M. Sibilio, A. Simonati, E. Fontana, A. Salviati, G. Akinci, C. Cereda, C. Dionisi-Vici, F. Deodato, A. d'Amico, A. d'Azzo, E. Bertini, M. Filocamo, M. Scarpa, M. di Rocco, C.J. Tifft, F. Ciani, S. Gasperini, E. Pasquini, R. Guerrini, M.A. Donati, and A. Morrone GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings Biochim. Biophys. Acta 1812 2011 782 790
129. S. Okada, and J.S. O'Brien Generalized gangliosidosis: beta-galactosidase deficiency Science (New York, N.Y.) 160 1968 1002 1004
130. L.S. Wolfe, J. Callahan, J.S. Fawcett, F. Andermann, and C.R. Scriver GM1-gangliosidosis without chondrodystrophy or visceromegaly. B-galactosidase deficiency with gangliosidosis and the excessive excretion of a keratan sulfate Neurology 20 1970 23 44
131. A. D'Azzo, G. Andria, P. Strisciuglio, and H. Galjaard C.R. Scriver, A. Beaudet, W.S. Sly, D. Valle, Metabolic Basis of Inherited Disease seventh ed. 1995 McGraw-Hill New York 2825 2837
132. K. Suzuki, and S. Kamoshita Chemical pathology of G-m-1-gangliosidosis (generalized gangliosidosis) J. Neuropathol. Exp. Neurol. 28 1969 25 73
133. A. Takamura, K. Higaki, K. Kajimaki, S. Otsuka, H. Ninomiya, J. Matsuda, K. Ohno, Y. Suzuki, and E. Nanba Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis Biochem. Biophys. Res. Commun. 367 2008 616 622
134. B. Boland, D.A. Smith, D. Mooney, S.S. Jung, D.M. Walsh, and F.M. Platt Macroautophagy is not directly involved in the metabolism of amyloid precursor protein J. Biol. Chem. 285 2010 37415 37426
135. J. Matsuda, O. Suzuki, A. Oshima, Y. Yamamoto, A. Noguchi, K. Takimoto, M. Itoh, Y. Matsuzaki, Y. Yasuda, S. Ogawa, Y. Sakata, E. Nanba, K. Higaki, Y. Ogawa, L. Tominaga, K. Ohno, H. Iwasaki, H. Watanabe, R.O. Brady, and Y. Suzuki Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis Proc. Natl. Acad. Sci. U. S. A. 100 2003 15912 15917
136. C.M. Weismann, J. Ferreira, A.M. Keeler, Q. Su, L. Qui, S.A. Shaffer, Z. Xu, G. Gao, and M. Sena-Esteves Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan Hum. Mol. Genet. 24 2015 4353 4364
137. A. Denden, and A.T. Franceschetti [Verticillate Cornea: A Symptom of Fabry-Anderson's Disease]. Bericht Uber die Zusammenkunft. Deutsche Ophthalmologische Gesellschaft 69 1969 145 149
138. K. Ogawa, K. Sugamata, N. Funamoto, T. Abe, T. Sato, K. Nagashima, and S. Ohkawa Restricted accumulation of globotriaosylceramide in the hearts of atypical cases of Fabry's disease Hum. Pathol. 21 1990 1067 1073
139. M. Elleder, V. Bradova, F. Smid, M. Budesinsky, K. Harzer, B. Kustermann-Kuhn, J. Ledvinova, K.,.V. Belohlavek, and V. Dorazilova Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy Virchows Arch. A Pathol. Anat. Histol. 417 1990 449 455
140. Y. Nagao, H. Nakashima, Y. Fukuhara, M. Shimmoto, A. Oshima, Y. Ikari, Y. Mori, H. Sakuraba, and Y. Suzuki Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A Clin. Genet. 39 1991 233 237
141. W. von Scheidt, C.M. Eng, T.F. Fitzmaurice, E. Erdmann, G. Hubner, E.G. Olsen, H. Christomanou, R. Kandolf, D.F. Bishop, and R.J. Desnick An atypical variant of Fabry's disease with manifestations confined to the myocardium N. Engl. J. Med. 324 1991 395 399
142. H.S. Bernstein, D.F. Bishop, K.H. Astrin, R. Kornreich, C.M. Eng, H. Sakuraba, and R.J. Desnick Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene J. Clin. Invest. 83 1989 1390 1399
143. H. Sakuraba, A. Oshima, Y. Fukuhara, M. Shimmoto, Y. Nagao, D.F. Bishop, R.J. Desnick, and Y. Suzuki Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease Am. J. Hum. Genet. 47 1990 784 789
144. R. Kornreich, D.F. Bishop, and R.J. Desnick Alpha-galactosidase A gene rearrangements causing Fabry disease. Identification of short direct repeats at breakpoints in an Alu-rich gene J. Biol. Chem. 265 1990 9319 9326
145. M. Oshima, K. Asano, S. Shibata, Y. Suzuki, and M. Masuzawa Urinary neutral glycosphingolipid analysis of patients with Fabry's disease; rapid isocratic elution from high-performance liquid chromatography as per-o-benzoyl derivatives Biochim. Biophys. Acta 1043 1990 157 160
146. M. Chevrier, N. Brakch, L. Celine, D. Genty, Y. Ramdani, S. Moll, M. Djavaheri-Mergny, C. Brasse-Lagnel, A.L. Annie Laquerriere, F. Barbey, and S. Bekri Autophagosome maturation is impaired in Fabry disease Autophagy 6 2010 589 599
147. M.P. Nelson, T.E. Tse, D.B. O'Quinn, S.M. Percival, E.A. Jaimes, D.G. Warnock, and J.J. Shacka Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice Acta Neuropathol. Commun. 2 2014 20
148. M.C. Liebau, F. Braun, K. Hopker, C. Weitbrecht, V. Bartels, R.U. Muller, S. Brodesser, M.A. Saleem, T. Benzing, B. Schermer, M. Cybulla, and C.E. Kurschat Dysregulated autophagy contributes to podocyte damage in Fabry's disease PLoS One 8 2013 e63506
149. C.A. Mapes, R.L. Anderson, C.C. Sweeley, R.J. Desnick, and W. Krivit Enzyme replacement in Fabry's disease, an inborn error of metabolism Science (New York, N.Y.) 169 1970 987 989
150. W.R. Wilcox, M. Banikazemi, N. Guffon, S. Waldek, P. Lee, G.E. Linthorst, R.J. Desnick, and D.P. Germain Long-term safety and efficacy of enzyme replacement therapy for Fabry disease Am. J. Hum. Genet. 75 2004 65 74
151. O. Lidove, M.L. West, G. Pintos-Morell, R. Reisin, K. Nicholls, L.E. Figuera, R. Parini, L.R. Carvalho, C. Kampmann, G.M. Pastores, and A. Mehta Effects of enzyme replacement therapy in Fabry disease - a comprehensive review of the medical literature Genet. Med. 12 2010 668 679
152. S.M. Rombach, C.E. Hollak, G.E. Linthorst, and M.G. Dijkgraaf Cost-effectiveness of enzyme replacement therapy for Fabry disease Orphanet J. Rare Dis. 8 2013 29
153. J. Goldblatt Type I gaucher disease J. Med. Genet. 25 1988 415 418
154. K.S. Hruska, M.E. LaMarca, C.R. Scott, and E. Sidransky Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) Hum. Mutat. 29 2008 567 583
155. K. Wong, E. Sidransky, A. Verma, T. Mixon, G.D. Sandberg, L.K. Wakefield, A. Morrison, A. Lwin, C. Colegial, J.M. Allman, and R. Schiffmann Neuropathology provides clues to the pathophysiology of Gaucher disease Mol. Genet. Metab. 82 2004 192 207
156. T. Farfel-Becker, E.B. Vitner, S.L. Kelly, J.R. Bame, J. Duan, V. Shinder, A.H. Merrill Jr., K. Dobrenis, and A.H. Futerman Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration Hum. Mol. Genet. 23 2014 843 854
157. Y. Sun, B. Liou, H. Ran, M.R. Skelton, M.T. Williams, C.V. Vorhees, K. Kitatani, Y.A. Hannun, D.P. Witte, Y.H. Xu, and G.A. Grabowski Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits Hum. Mol. Genet. 19 2010 1088 1097
158. L.D. Osellame, A.A. Rahim, I.P. Hargreaves, M.E. Gegg, A. Richard-Londt, S. Brandner, S.N. Waddington, A.H. Schapira, and M.R. Duchen Mitochondria and quality control defects in a mouse model of Gaucher disease-links to Parkinson's disease Cell Metab. 17 2013 941 953
159. Y.H. Xu, K. Xu, Y. Sun, B. Liou, B. Quinn, R.H. Li, L. Xue, W. Zhang, K.D. Setchell, D. Witte, and G.A. Grabowski Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice Hum. Mol. Genet. 23 2014 3943 3957
160. M. Tatti, M. Motta, S. Di Bartolomeo, S. Scarpa, V. Cianfanelli, F. Cecconi, and R. Salvioli Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in Sap C-deficient fibroblasts Hum. Mol. Genet. 21 2012 5159 5173
161. N. Raben, V. Hill, L. Shea, S. Takikita, R. Baum, N. Mizushima, E. Ralston, and P. Plotz Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease Hum. Mol. Genet. 17 2008 3897 3908
162. C. Settembre, C. Di Malta, V.A. Polito, M. Garcia Arencibia, F. Vetrini, S. Erdin, S.U. Erdin, T. Huynh, D. Medina, P. Colella, M. Sardiello, D.C. Rubinsztein, and A. Ballabio TFEB links autophagy to lysosomal biogenesis Science (New York, N.Y.) 332 2011 1429 1433
163. R.O. Brady Benefits from unearthing "a biochemical Rosetta Stone" J. Biol. Chem. 285 2010 41216 41221
164. T.M. Cox Recommendations for treating patients with Gaucher disease with emerging enzyme products Blood Cells Mol. Dis. 44 2010 84 85
165. J. Aerts, U. Yasothan, and P. Kirkpatrick Velaglucerase alfa Nat. Rev. Drug Discov. 9 2010 837 838
166. C.E. Hollak An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease Core Evid. 7 2012 15 20
167. B. Brumshtein, P. Salinas, B. Peterson, V. Chan, I. Silman, J.L. Sussman, P.J. Savickas, G.S. Robinson, and A.H. Futerman Characterization of gene-activated human acid-beta-glucosidase: crystal structure, glycan composition, and internalization into macrophages Glycobiology 20 2010 24 32
168. L.L. Bennett, and D. Mohan Gaucher disease and its treatment options Ann. Pharmacother. 47 2013 1182 1193
169. K.A. McEachern, J. Fung, S. Komarnitsky, C.S. Siegel, W.L. Chuang, E. Hutto, J.A. Shayman, G.A. Grabowski, J.M. Aerts, S.H. Cheng, D.P. Copeland, and J. Marshall A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease Mol. Genet. Metab. 91 2007 259 267
170. M.J. Peterschmitt, A. Burke, L. Blankstein, S.E. Smith, A.C. Puga, W.G. Kramer, J.A. Harris, D. Mathews, and P.L. Bonate Safety, tolerability, and pharmacokinetics of eliglustat tartrate (Genz-112638) after single doses, multiple doses, and food in healthy volunteers J. Clin. Pharmacol. 51 2011 695 705
171. E. Lukina, N. Watman, E.A. Arreguin, M. Banikazemi, M. Dragosky, M. Iastrebner, H. Rosenbaum, M. Phillips, G.M. Pastores, D.I. Rosenthal, M. Kaper, T. Singh, A.C. Puga, P.L. Bonate, and M.J. Peterschmitt A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1 Blood 116 2010 893 899
172. E. Lukina, N. Watman, E.A. Arreguin, M. Dragosky, M. Iastrebner, H. Rosenbaum, M. Phillips, G.M. Pastores, R.S. Kamath, D.I. Rosenthal, M. Kaper, T. Singh, A.C. Puga, and M.J. Peterschmitt Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study Blood 116 2010 4095 4098
173. M. Connock, A. Burls, E. Frew, A. Fry-Smith, A. Juarez-Garcia, C. McCabe, A. Wailoo, K. Abrams, N. Cooper, A. Sutton, A. O'Hagan, and D. Moore The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review Health Technol. Assess. Winchester, England 10 2006 (iii-iv, ix-136)
174. J.A. Lim, L. Li, and N. Raben Pompe disease: from pathophysiology to therapy and back again Front. Aging Neurosci. 6 2014 177
175. C. Spampanato, E. Feeney, L. Li, M. Cardone, J.A. Lim, F. Annunziata, H. Zare, R. Polishchuk, R. Puertollano, G. Parenti, A. Ballabio, and N. Raben Transcription factor EB (TFEB) is a new therapeutic target for pompe disease EMBO Mol. Med. 5 2013 691 706
176. A.C. Nascimbeni, M. Fanin, E. Masiero, C. Angelini, and M. Sandri The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII) Cell Death Differ. 19 2012 1698 1708
177. N. Raben, C. Schreiner, R. Baum, S. Takikita, S. Xu, T. Xie, R. Myerowitz, M. Komatsu, J.H. Van der Meulen, K. Nagaraju, E. Ralston, and P.H. Plotz Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder-murine Pompe disease Autophagy 6 2010 1078 1089
178. C. Settembre, A. Fraldi, L. Jahreiss, C. Spampanato, C. Venturi, D. Medina, R. de Pablo, C. Tacchetti, D.C. Rubinsztein, and A. Ballabio A block of autophagy in lysosomal storage disorders Hum. Mol. Genet. 17 2008 119 129
179. A. Fraldi, F. Annunziata, A. Lombardi, H.J. Kaiser, D.L. Medina, C. Spampanato, A.O. Fedele, R. Polishchuk, N.C. Sorrentino, K. Simons, and A. Ballabio Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders EMBO J. 29 2010 3607 3620
180. C. Di Malta, J.D. Fryer, C. Settembre, and A. Ballabio Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder Proc. Natl. Acad. Sci. U. S. A. 109 2012 E2334 E2342
181. C. Settembre, E. Arteaga-Solis, M.D. McKee, R. de Pablo, Q. Al Awqati, A. Ballabio, and G. Karsenty Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification Genes Dev. 22 2008 2645 2650
182. R. de Pablo-Latorre, A. Saide, E.V. Polishhuck, E. Nusco, A. Fraldi, and A. Ballabio Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases Hum. Mol. Genet. 21 2012 1770 1781
183. K. Horinouchi, S. Erlich, D.P. Perl, K. Ferlinz, C.L. Bisgaier, K. Sandhoff, R.J. Desnick, C.L. Stewart, and E.H. Schuchman Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease Nat. Genet. 10 1995 288 293
184. B. Otterbach, and W. Stoffel Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease) Cell 81 1995 1053 1061
185. E.D. Carstea, J.A. Morris, K.G. Coleman, S.K. Loftus, D. Zhang, C. Cummings, J. Gu, M.A. Rosenfeld, W.J. Pavan, D.B. Krizman, J. Nagle, M.H. Polymeropoulos, S.L. Sturley, Y.A. Ioannou, M.E. Higgins, M. Comly, A. Cooney, A. Brown, C.R. Kaneski, E.J. Blanchette-Mackie, N.K. Dwyer, E.B. Neufeld, T.Y. Chang, L. Liscum, J.F. Strauss 3rd, K. Ohno, M. Zeigler, R. Carmi, J. Sokol, D. Markie, R.R. O'Neill, O.P. van Diggelen, M. Elleder, M.C. Patterson, R.O. Brady, M.T. Vanier, P.G. Pentchev, and D.A. Tagle Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis Science (New York, N.Y.) 277 1997 228 231
186. S. Naureckiene, D.E. Sleat, H. Lackland, A. Fensom, M.T. Vanier, R. Wattiaux, M. Jadot, and P. Lobel Identification of HE1 as the second gene of Niemann-Pick C disease Science (New York, N.Y.) 290 2000 2298 2301
187. H.J. Kwon, L. Abi-Mosleh, M.L. Wang, J. Deisenhofer, J.L. Goldstein, M.S. Brown, and R.E. Infante Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol Cell 137 2009 1213 1224
188. E.H. Schuchman The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease J. Inherit. Metab. Dis. 30 2007 654 663
189. B. Karten, K.B. Peake, and J.E. Vance Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells Biochim. Biophys. Acta 1791 2009 659 670
190. -/- mouse brain Am. J. Pathol. 171 2007 962 975
191. -/- mouse brain Brain Res. 1270 2009 140 151
192. C.D. Pacheco, R. Kunkel, and A.P. Lieberman Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects Hum. Mol. Genet. 16 2007 1495 1503
193. V. Meske, J. Erz, T. Priesnitz, and T.G. Ohm The autophagic defect in Niemann-Pick disease type C neurons differs from somatic cells and reduces neuronal viability Neurobiol. Dis. 64 2014 88 97
194. M.P. Ordonez, E.A. Roberts, C.U. Kidwell, S.H. Yuan, W.C. Plaisted, and L.S. Goldstein Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1 Hum. Mol. Genet. 21 2012 2651 2662
195. D. Maetzel, S. Sarkar, H. Wang, L. Abi-Mosleh, P. Xu, A.W. Cheng, Q. Gao, M. Mitalipova, and R. Jaenisch Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells Stem Cell Rep. 2 2014 866 880
196. S. Sarkar, B. Carroll, Y. Buganim, D. Maetzel, A.H. Ng, J.P. Cassady, M.A. Cohen, S. Chakraborty, H. Wang, E. Spooner, H. Ploegh, J. Gsponer, V.I. Korolchuk, and R. Jaenisch Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease Cell Rep. 2013
197. H. Lee, J.K. Lee, M.H. Park, Y.R. Hong, H.H. Marti, H. Kim, Y. Okada, M. Otsu, E.J. Seo, J.H. Park, J.H. Bae, N. Okino, X. He, E.H. Schuchman, J.S. Bae, and H.K. Jin Pathological roles of the VEGF/SphK pathway in Niemann-Pick type C neurons Nat. Commun. 5 2014 5514
198. D.C. Ko, L. Milenkovic, S.M. Beier, H. Manuel, J. Buchanan, and M.P. Scott Cell-autonomous death of cerebellar Purkinje neurons with autophagy in Niemann-Pick type C disease PLoS Genet. 1 2005 e86
199. S. Sarkar, D. Maetzel, V.I. Korolchuk, and R. Jaenisch Restarting stalled autophagy a potential therapeutic approach for the lipid storage disorder, Niemann-Pick type C1 disease Autophagy 10 2014 1137 1140
200. E. Gabande-Rodriguez, P. Boya, V. Labrador, C.G. Dotti, and M.D. Ledesma High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A Cell Death Differ. 21 2014 864 875
201. B.X. Wu, J. Fan, N.P. Boyer, R.W. Jenkins, Y. Koutalos, Y.A. Hannun, and C.E. Crosson Lack of acid sphingomyelinase induces age-related retinal degeneration PLoS One 10 2015 e0133032
202. R.H. Lachmann, D. te Vruchte, E. Lloyd-Evans, G. Reinkensmeier, D.J. Sillence, L. Fernandez-Guillen, R.A. Dwek, T.D. Butters, T.M. Cox, and F.M. Platt Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C Neurobiol. Dis. 16 2004 654 658
203. K.A. Lyseng-Williamson Miglustat: a review of its use in Niemann-Pick disease type C Drugs 74 2014 61 74
204. -/- mouse Proc. Natl. Acad. Sci. U. S. A. 106 2009 2377 2382
205. B. Liu, C.M. Ramirez, A.M. Miller, J.J. Repa, S.D. Turley, and J.M. Dietschy Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid J. Lipid Res. 51 2010 933 944
206. C.D. Davidson, N.F. Ali, M.C. Micsenyi, G. Stephney, S. Renault, K. Dobrenis, D.S. Ory, M.T. Vanier, and S.U. Walkley Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression PLoS One 4 2009 e6951
207. J.E. Vance, and B. Karten Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin J. Lipid Res. 55 2014 1609 1621
208. M. Matsuo, M. Togawa, K. Hirabaru, S. Mochinaga, A. Narita, M. Adachi, M. Egashira, T. Irie, and K. Ohno Effects of cyclodextrin in two patients with Niemann-Pick Type C disease Mol. Genet. Metab. 108 2013 76 81
209. C.H. Vite, J.H. Bagel, G.P. Swain, M. Prociuk, T.U. Sikora, V.M. Stein, P. O'Donnell, T. Ruane, S. Ward, A. Crooks, S. Li, E. Mauldin, S. Stellar, M. De Meulder, M.L. Kao, D.S. Ory, C. Davidson, M.T. Vanier, and S.U. Walkley Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease Sci. Transl. Med. 7 2015 276ra226
210. K.B. Peake, and J.E. Vance Normalization of cholesterol homeostasis by 2-hydroxypropyl-beta-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice J. Biol. Chem. 287 2012 9290 9298
211. S.Y. Kuo, A.B. Castoreno, L.N. Aldrich, K.G. Lassen, G. Goel, V. Dancik, P. Kuballa, I. Latorre, K.L. Conway, S. Sarkar, D. Maetzel, R. Jaenisch, P.A. Clemons, S.L. Schreiber, A.F. Shamji, and R.J. Xavier Small-molecule enhancers of autophagy modulate cellular disease phenotypes suggested by human genetics Proc. Natl. Acad. Sci. U. S. A. 112 2015 E4281 E4287
212. M.J. Elrick, T. Yu, C. Chung, and A.P. Lieberman Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease Hum. Mol. Genet. 21 2012 4876 4887
213. A. Tamura, and N. Yui Threaded macromolecules as a versatile framework for biomaterials Chem. Commun. 50 2014 13433 13446
214. A. Harada, A. Hashidzume, H. Yamaguchi, and Y. Takashima Polymeric rotaxanes Chem. Rev. 109 2009 5974 6023
215. A. Tamura, and N. Yui Beta-cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease J. Biol. Chem. 290 2015 9442 9454
216. E.R. Berman, N. Livni, E. Shapira, S. Merin, and I.S. Levij Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis J. Pediatr. 84 1974 519 526
217. S. Merin, N. Livni, E.R. Berman, and S. Yatziv Mucolipidosis IV: ocular, systemic, and ultrastructural findings Investig. Ophthalmol. 14 1975 437 448
218. I. Tellez-Nagel, I. Rapin, T. Iwamoto, A.B. Johnson, W.T. Norton, and H. Nitowsky Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy Arch. Neurol. 33 1976 828 835
219. R. Bargal, N. Avidan, E. Ben-Asher, Z. Olender, M. Zeigler, A. Frumkin, A. Raas-Rothschild, G. Glusman, D. Lancet, and G. Bach Identification of the gene causing mucolipidosis type IV Nat. Genet. 26 2000 118 123
220. J.M. LaPlante, J. Falardeau, M. Sun, M. Kanazirska, E.M. Brown, S.A. Slaugenhaupt, and P.M. Vassilev Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway FEBS Lett. 532 2002 183 187
221. J.M. LaPlante, C.P. Ye, S.J. Quinn, E. Goldin, E.M. Brown, S.A. Slaugenhaupt, and P.M. Vassilev Functional links between mucolipin-1 and Ca2 +- dependent membrane trafficking in mucolipidosis IV Biochem. Biophys. Res. Commun. 322 2004 1384 1391
222. A.A. Soyombo, S. Tjon-Kon-Sang, Y. Rbaibi, E. Bashllari, J. Bisceglia, S. Muallem, and K. Kiselyov TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity J. Biol. Chem. 281 2006 7294 7301
223. J.J. Jennings Jr., J.H. Zhu, Y. Rbaibi, X. Luo, C.T. Chu, and K. Kiselyov Mitochondrial aberrations in mucolipidosis Type IV J. Biol. Chem. 281 2006 39041 39050
224. J.M. LaPlante, M. Sun, J. Falardeau, D. Dai, E.M. Brown, S.A. Slaugenhaupt, and P.M. Vassilev Lysosomal exocytosis is impaired in mucolipidosis type IV Mol. Genet. Metab. 89 2006 339 348
225. S. Vergarajauregui, P.S. Connelly, M.P. Daniels, and R. Puertollano Autophagic dysfunction in mucolipidosis type IV patients Hum. Mol. Genet. 17 2008 2723 2737
226. C. Curcio-Morelli, F.A. Charles, M.C. Micsenyi, Y. Cao, B. Venugopal, M.F. Browning, K. Dobrenis, S.L. Cotman, S.U. Walkley, and S.A. Slaugenhaupt Macroautophagy is defective in mucolipin-1-deficient mouse neurons Neurobiol. Dis. 40 2010 370 377
227. K. Venkatachalam, A.A. Long, R. Elsaesser, D. Nikolaeva, K. Broadie, and C. Montell Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells Cell 135 2008 838 851
228. B. Venugopal, N.T. Mesires, J.C. Kennedy, C. Curcio-Morelli, J.M. Laplante, J.F. Dice, and S.A. Slaugenhaupt Chaperone-mediated autophagy is defective in mucolipidosis type IV J. Cell. Physiol. 219 2009 344 353
229. C.C. Chen, M. Keller, M. Hess, R. Schiffmann, N. Urban, A. Wolfgardt, M. Schaefer, F. Bracher, M. Biel, C. Wahl-Schott, and C. Grimm A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV Nat. Commun. 5 2014 4681
230. A. Jalanko, and T. Braulke Neuronal ceroid lipofuscinoses Biochim. Biophys. Acta, Mol. Cell Res. 1793 2009 697 709
231. P. Santavuori Neuronal ceroid-lipofuscinoses in childhood Brain Dev. 10 1988 80 83
232. M. Haltia The neuronal ceroid-lipofuscinoses: from past to present Biochim. Biophys. Acta 1762 2006 850 856
233. A. Simonati, F. Pezzini, F. Moro, and F.M. Santorelli Neuronal ceroid lipofuscinosis: the increasing spectrum of an old disease Curr. Mol. Med. 14 2014 1043 1051
234. U.T. Brunk, and A. Terman Lipofuscin: mechanisms of age-related accumulation and influence on cell function Free Radic. Biol. Med. 33 2002 611 619
235. M. Koike, H. Nakanishi, P. Saftig, J. Ezaki, K. Isahara, Y. Ohsawa, W. Schulz-Schaeffer, T. Watanabe, S. Waguri, S. Kametaka, M. Shibata, K. Yamamoto, E. Kominami, C. Peters, K. von Figura, and Y. Uchiyama Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons J. Neurosci. 20 2000 6898 6906
236. M. Koike, M. Shibata, S. Waguri, K. Yoshimura, I. Tanida, E. Kominami, T. Gotow, C. Peters, K. von Figura, N. Mizushima, P. Saftig, and Y. Uchiyama Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease) Am. J. Pathol. 167 2005 1713 1728
237. J.J. Shacka, B.J. Klocke, C. Young, M. Shibata, J.W. Olney, Y. Uchiyama, P. Saftig, and K.A. Roth Cathepsin D deficiency induces persistent neurodegeneration in the absence of Bax-dependent apoptosis J. Neurosci. 27 2007 2081 2090
238. T.J. Lerner, R.-M.N. Boustany, J.W. Anderson, K.L. D'Arigo, K. Schlumpf, A.J. Buckler, J.F. Gusella, and J.L. Haines Isolation of a novel gene underlying batten disease, CLN3 Cell 82 1995 949 957
239. Y. Cao, J.A. Espinola, E. Fossale, A.C. Massey, A.M. Cuervo, M.E. MacDonald, and S.L. Cotman Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis J. Biol. Chem. 281 2006 20483 20493
240. S.L. Cotman, V. Vrbanac, L.A. Lebel, R.L. Lee, K.A. Johnson, L.R. Donahue, A.M. Teed, K. Antonellis, R.T. Bronson, T.J. Lerner, and M.E. MacDonald Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth Hum. Mol. Genet. 11 2002 2709 2721
241. X. Lojewski, J.F. Staropoli, S. Biswas-Legrand, A.M. Simas, L. Haliw, M.K. Selig, S.H. Coppel, K.A. Goss, A. Petcherski, U. Chandrachud, S.D. Sheridan, D. Lucente, K.B. Sims, J.F. Gusella, D. Sondhi, R.G. Crystal, P. Reinhardt, J. Sterneckert, H. Scholer, S.J. Haggarty, A. Storch, A. Hermann, and S.L. Cotman Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway Hum. Mol. Genet. 23 2014 2005 2022
242. S. Kang, T.H. Heo, and S.J. Kim Altered levels of alpha-synuclein and sphingolipids in Batten disease lymphoblast cells Gene 539 2014 181 185
243. M. Thelen, M. Damme, M. Schweizer, C. Hagel, A.M. Wong, J.D. Cooper, T. Braulke, and G. Galliciotti Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis PLoS One 7 2012 e35493
244. N. Cannelli, B. Garavaglia, A. Simonati, C. Aiello, C. Barzaghi, F. Pezzini, M.R. Cilio, R. Biancheri, M. Morbin, B. Dalla Bernardina, T. Granata, A. Tessa, F. Invernizzi, A. Pessagno, R. Boldrini, F. Zibordi, L. Grazian, D. Claps, R. Carrozzo, S.E. Mole, N. Nardocci, and F.M. Santorelli Variant late infantile ceroid lipofuscinoses associated with novel mutations in CLN6 Biochem. Biophys. Res. Commun. 379 2009 892 897
245. U. Chandrachud, M.W. Walker, A.M. Simas, S. Heetveld, A. Petcherski, M. Klein, H. Oh, P. Wolf, W.N. Zhao, S. Norton, S.J. Haggarty, E. Lloyd-Evans, and S.L. Cotman Unbiased cell-based screening in a neuronal cell model of Batten disease highlights an interaction between Ca2 + homeostasis, autophagy, and CLN3 protein function J. Biol. Chem. 290 2015 14361 14380
246. M.L. Schultz, L. Tecedor, C.S. Stein, M.A. Stamnes, and B.L. Davidson CLN3 deficient cells display defects in the ARF1-Cdc42 pathway and actin-dependent events PLoS One 9 2014 e96647
247. N.R. Hackett, D.E. Redmond, D. Sondhi, E.L. Giannaris, E. Vassallo, J. Stratton, J. Qiu, S.M. Kaminsky, M.L. Lesser, G.S. Fisch, S.D. Rouselle, and R.G. Crystal Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates Hum. Gene Ther. 16 2005 1484 1503
248. S. Worgall, D. Sondhi, N.R. Hackett, B. Kosofsky, M.V. Kekatpure, N. Neyzi, J.P. Dyke, D. Ballon, L. Heier, B.M. Greenwald, P. Christos, M. Mazumdar, M.M. Souweidane, M.G. Kaplitt, and R.G. Crystal Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA Hum. Gene Ther. 19 2008 463 474